Edition:
United Kingdom

Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

70.20EUR
13 Sep 2019
Change (% chg)

€0.30 (+0.43%)
Prev Close
€69.90
Open
€70.20
Day's High
€70.55
Day's Low
€69.35
Volume
84,799
Avg. Vol
94,870
52-wk High
€78.85
52-wk Low
€53.10

Latest Key Developments (Source: Significant Developments)

Biomerieux H1 Net Attributable Income Up At Eur 141 Mln
Wednesday, 4 Sep 2019 

Sept 4 (Reuters) - BIOMERIEUX SA ::FIRST-HALF 2019 RESULTS.H1: EUR 1,275 MILLION IN SALES.2019 TARGETS CONFIRMED.IN H1 INCREASE IN CONTRIBUTIVE OPERATING INCOME BEFORE NON-RECURRING ITEMS, UP TO EUR 198 MILLION OR 15.5% OF SALES, IN LINE WITH ANNUAL TARGETS.H1 NET ATTRIBUTABLE INCOME EUR 141 MILLION VERSUS EUR 134 MILLION YEAR AGO.GROSS PROFIT FOR FIRST SIX MONTHS OF YEAR CAME TO EUR 710 MILLION OR 55.7% OF SALES.FREE CASH FLOW CAME IN AT EUR 55 MILLION IN SIX MONTHS TO JUNE 30, 2019, COMPARED TO EUR 98 MILLION IN FIRST-HALF 2018.H1 SALES EUR 1.28 BILLION VERSUS EUR 1.17 BILLION YEAR AGO.H1 OPERATING INCOME EUR 189 MILLION VERSUS EUR 177 MILLION YEAR AGO.  Full Article

BioMerieux Increases Its Holding In Hybiome To 67%
Thursday, 6 Jun 2019 

June 6 (Reuters) - BIOMERIEUX SA ::BIOMÉRIEUX INCREASES ITS HOLDING IN HYBIOME FROM 54% TO 67%.AN ADDITIONAL 13% STAKE HAS BEEN ACQUIRED FOR ABOUT 20 MILLION EUROS.ADDITIONAL 13% STAKE HAS BEEN ACQUIRED FOR ABOUT 20 MILLION EUROS.FOLLOWING THIS TRANSACTION, BIOMÉRIEUX NOW HOLDS 67% OF SHARES OF HYBIOME.  Full Article

Baxter And Biomérieux Collaborate On Identification And Treatment Of Acute Kidney Injury
Tuesday, 19 Mar 2019 

March 19 (Reuters) - BAXTER INTERNATIONAL INC ::BAXTER AND BIOMÉRIEUX ANNOUNCE COLLABORATION TO IMPROVE IDENTIFICATION AND TREATMENT OF ACUTE KIDNEY INJURY.  Full Article

Biomerieux FY Operating Income Up At 344 Million Euros
Wednesday, 27 Feb 2019 

Feb 27 (Reuters) - BIOMERIEUX SA ::FY SALES EUR 2.42 BILLION VERSUS EUR 2.29 BILLION YEAR AGO.FY OPERATING INCOME EUR 344 MILLION VERSUS EUR 315 MILLION YEAR AGO.FY NET INCOME OF CONSOLIDATED COMPANIES EUR 256 MILLION VERSUS EUR 238 MILLION YEAR AGO.FOR 2019: ORGANIC GROWTH IN SALES OF BETWEEN 7.0% AND 8.5%, AT CONSTANT EXCHANGE RATES AND SCOPE OF CONSOLIDATION.FOR 2019: CONTRIBUTIVE OPERATING INCOME BEFORE NON-RECURRING ITEMS OF BETWEEN EUR 385 MILLION AND EUR 400 MILLION, AT CURRENT EXCHANGE RATES.WILL RECOMMEND THAT SHAREHOLDERS AT THE ANNUAL GENERAL MEETING ON MAY 23, 2019 APPROVE A DIVIDEND OF €0.35 PER SHARE FOR FY.BIOMÉRIEUX EXPECTS SALES GROWTH TO BE WEAKER IN FIRST-QUARTER 2019 THAN IN THE OTHER QUARTERS.  Full Article

Biomérieux Acquires A Majority Stake In Hybiome
Friday, 9 Nov 2018 

Nov 9 (Reuters) - BIOMERIEUX SA ::BIOMÉRIEUX ACQUIRES A MAJORITY STAKE IN HYBIOME AND STRENGTHENS ITS PRESENCE BOTH IN CHINA AND IN THE IMMUNOASSAY MARKET.ACQUISITION OF 54% OF SHARES OF HYBIOME RELIES ON A EUR 165 MILLION VALUATION, ON TOP OF WHICH ADDITIONAL EXPENSES OF 25 MILLION EUROS WERE INCURRED AS CONSIDERATION FOR ADDITIONAL ASSETS.  Full Article

Biomerieux 9-Month Sales Up At 1.75 Billion Euros
Thursday, 18 Oct 2018 

Oct 18 (Reuters) - BIOMERIEUX SA ::BIOMÉRIEUX – BUSINESS REVIEW FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018.9M EUR 1,749 MILLION IN SALES UP 4.5% AS REPORTED.ON TRACK TO ACHIEVING ITS FINANCIAL OBJECTIVES FOR YEAR.  Full Article

Biomerieux Launches Endozyme II Go
Thursday, 31 May 2018 

May 31 (Reuters) - BIOMERIEUX SA ::BIOMÉRIEUX LAUNCHES ENDOZYME® II GO, A TEST FOR THE DETECTION OF ENDOTOXINS IN PHARMACEUTICAL MICROBIOLOGY CONTROL.  Full Article

Biomerieux FY Sales Up At 2.29 Billion Euros
Wednesday, 28 Feb 2018 

Feb 28 (Reuters) - BIOMERIEUX SA ::FY SALES EUR 2.29 BILLION VERSUS EUR 2.10 BILLION YEAR AGO.FY OPERATING INCOME EUR 315 MILLION VERSUS EUR 282 MILLION YEAR AGO.FY RESULT EUR 238 MILLION VERSUS EUR 179 MILLION YEAR AGO.FOR 2018 EXPECTS ORGANIC SALES GROWTH OF BETWEEN 8 AND 9 PERCENT, AT CONSTANT EXCHANGE RATES AND PERIMETER.FOR 2018 EXPECTS CONTRIBUTING CURRENT OPERATING INCOME OF BETWEEN € 325 AND € 345 MILLION.TO PROPOSE A DIVIDEND OF EUR 0.34 PER SHARE.  Full Article

Biomerieux Q3 sales up at ‍​1.67 billion euros
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - BIOMERIEUX SA ::Q3 SALES EUR ‍​1.67 BILLION VERSUS EUR 1.51 BILLION YEAR AGO.  Full Article

French and Benelux stocks-Factors to watch on Sept. 4

Sept 4 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.